Skip to main content

Ovarian cancer, version 3.2012.

Publication ,  Journal Article
Morgan, RJ; Alvarez, RD; Armstrong, DK; Burger, RA; Castells, M; Chen, L-M; Copeland, L; Crispens, MA; Gershenson, D; Gray, H; Hakam, A ...
Published in: J Natl Compr Canc Netw
November 1, 2012

These NCCN Guidelines Insights focus on the major updates for the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ovarian Cancer by describing how and why the new recommendations were made. The 6 update topics were selected based on recent important updates in the guidelines and on debate among panel members about recent clinical trials, and include: 1) screening, 2) diagnostic tests for assessing pelvic masses, 3) primary treatment using neoadjuvant chemotherapy, 4) primary adjuvant treatment using bevacizumab in combination with chemotherapy, 5) therapy for recurrent disease, and 6) management of drug/hypersensitivity reactions. These NCCN Guidelines Insights also discuss why some recommendations were not made (eg, panel members did not feel the new data warranted changing the guideline). See "Updates" in the NCCN Guidelines for Ovarian Cancer for a complete list of all the recent revisions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 1, 2012

Volume

10

Issue

11

Start / End Page

1339 / 1349

Location

United States

Related Subject Headings

  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Neoadjuvant Therapy
  • Molecular Targeted Therapy
  • Humans
  • Female
  • Early Detection of Cancer
  • Chemotherapy, Adjuvant
  • Antineoplastic Combined Chemotherapy Protocols
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Morgan, R. J., Alvarez, R. D., Armstrong, D. K., Burger, R. A., Castells, M., Chen, L.-M., … National Comprehensive Cancer Network, . (2012). Ovarian cancer, version 3.2012. J Natl Compr Canc Netw, 10(11), 1339–1349. https://doi.org/10.6004/jnccn.2012.0140
Morgan, Robert J., Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Mariana Castells, Lee-may Chen, Larry Copeland, et al. “Ovarian cancer, version 3.2012.J Natl Compr Canc Netw 10, no. 11 (November 1, 2012): 1339–49. https://doi.org/10.6004/jnccn.2012.0140.
Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen L-M, et al. Ovarian cancer, version 3.2012. J Natl Compr Canc Netw. 2012 Nov 1;10(11):1339–49.
Morgan, Robert J., et al. “Ovarian cancer, version 3.2012.J Natl Compr Canc Netw, vol. 10, no. 11, Nov. 2012, pp. 1339–49. Pubmed, doi:10.6004/jnccn.2012.0140.
Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen L-M, Copeland L, Crispens MA, Gershenson D, Gray H, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O’Malley DM, Penson RT, Remmenga SW, Sabbatini P, Santoso JT, Schilder RJ, Schink J, Teng N, Werner TL, Hughes M, Dwyer MA, National Comprehensive Cancer Network. Ovarian cancer, version 3.2012. J Natl Compr Canc Netw. 2012 Nov 1;10(11):1339–1349.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 1, 2012

Volume

10

Issue

11

Start / End Page

1339 / 1349

Location

United States

Related Subject Headings

  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Neoadjuvant Therapy
  • Molecular Targeted Therapy
  • Humans
  • Female
  • Early Detection of Cancer
  • Chemotherapy, Adjuvant
  • Antineoplastic Combined Chemotherapy Protocols